Trial Profile
A Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Oral Administration of DA-8010 in Healthy Subjects
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Jun 2018
Price :
$35
*
At a glance
- Drugs Velufenacin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Dong-A ST
- 13 Jul 2016 New trial record